Clinical Trials Detail

Treating Patients With Locally Advanced or Metastatic Recurrent HR+ Breast Cancer

A Randomized Ph. III Trial of Endocrine Therapy plus Entinostat/Placebo in Patients with Hormone Receptor+ Advanced Breast Cancer

Objective
CategoryInformation
Study #:

E2112

Anatomic Site:

Breast

Histology: Breast Cancer
Mutation:
  • HER2/NEU Negative
  • Estrogen Receptor (ER) Positive
  • Progesterone Receptor (PR) Positive
Stage: Stage II/locally advanced or metastatic breast cancer
Treatment Phase: ER and/or PR positive histologically confirmed adenocarcinoma at any time during treatment prior to study. May have received only one prior chemotherapy regiment.
Location:
Study Link: https://clinicaltrials.gov/ct2/show/NCT02115282?term=E2112&rank=1

Clinical Trial Categories

  • Breast